{"contentid": 488296, "importid": NaN, "name": "TherapeuticsMD and Theramex gain UK and Belgium approval for HRT therapy", "introduction": "TherapeuticsMD has announced that Bijuve (estradiol and progesterone capsules) has received approval from the UK\u00e2\u0080\u0099s Medicines and Healthcare products Regulatory Agency (MHRA) and from the Federal Agency for Medicines and Health Products (FAMHP) for use in Belgium under Bijuva.", "content": "<p>US women&rsquo;s healthcare specialist TherapeuticsMD&rsquo;s (Nasdaq: TXMD) shares were up 13.6% to $1.50 in pre-market trading after it announced that Bijuve (estradiol and progesterone capsules) has received approval from the UK&rsquo;s Medicines and Healthcare products Regulatory Agency (MHRA) and from the Federal Agency for Medicines and Health Products (FAMHP) for use in Belgium under Bijuva.</p>\n<p>In June 2019, Therapeutics MD licensed fellow women&rsquo;s health specialist UK-based Theramex to commercialize Bijuva and Imvexxy (estradiol vaginal inserts) outside of the USA, Canada and Israel.</p>\n<h2><strong>Under review in several European countries</strong></h2>\n<p>A decentralized procedure (DCP) for the regulatory approval of Bijuva in several European countries was completed in February. Following this each country undertakes a national process which includes approvals for labelling and other country specific requirements. Theramex expects approvals from other major European Union countries shortly.</p>\n<p>&ldquo;The approval of Bijuve in the UK and Bijuva in Belgium marks a significant accomplishment by Theramex that offers a new treatment option to post-menopausal women,&rdquo; said Robert Finizio, chief executive of TherapeuticsMD.</p>\n<p>&ldquo;We are excited to bring this first and only combination of micronized progesterone and estradiol to the UK and Belgium through our license agreement with TherapeuticsMD,&rdquo; added Robert Stewart, CEO of Theramex.</p>\n<p>Under the terms of the license agreement related to Bijuva, Theramex will pay TherapeuticsMD a milestone fee for the regulatory approval in certain specified European markets of Bijuva, sales milestone fees based upon certain aggregate annual net sales of the drug, and royalties based on aggregate annual net sales in licensed territories.</p>", "date": "2021-04-09 12:31:00", "meta_title": "TherapeuticsMD and Theramex gain UK and Belgium approval for HRT thera", "meta_keywords": "TherapeuticsMD, Theramex, Bijuve, Bijuva, Approval, UK, Belgium,  HRT therapy", "meta_description": "TherapeuticsMD and Theramex gain UK and Belgium approval for HRT therapy", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-09 12:30:22", "updated": "2021-04-09 12:40:52", "access": NaN, "url": "https://www.thepharmaletter.com/article/therapeuticsmd-and-theramex-gain-uk-and-belgium-approval-for-hrt-therapy", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "therapeuticsmd-large.jpg", "image2id": "therapeuticsmd-small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Women's health", "topic_tag": "Focus On, Medicines and Healthcare products Regulatory Agency (MHRA), Regulation", "geography_tag": "Belgium, UK, USA", "company_tag": "Theramex, TherapeuticsMD", "drug_tag": "Bijuva", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": "HRT", "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-09 12:31:00"}